44 BOARD OF DIRECTORS AND COMPANY SECRETARY 1,2 1 1,2, 3 1,2, 3 1,2, 3 1,2, 3 Bob Lawson Karim Bitar Stephen Wilson Nigel Turner Lysanne Gray Professor Duncan Lykele van der Broek Lesley Knox Professor Ian Dan Hartley 1,2, 3 1,2, 3 Non-Executive Chief Executive Group Finance Director Senior Independent Non-Executive Director Maskell Non-Executive Director Non-Executive Director Charles Group General Counsel Chairman Non-Executive Director Audit Committee Chair Non-Executive Director Non-Executive Director and Company Nomination Remuneration Secretary Committee Chair Committee Chair Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Appointment November 2010 September 2011 January 2013 January 2008 April 2016 April 2014 July 2014 June 2018 July 2018 June 2014 Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Significant experience Extensive experience International experience Substantial experience Significant experience of Co-founder of several Vast experience of Broad international, Entrepreneurial scientist, Significant experience of leading international of leading international, in France and the US of international business risk management, audit, biotech companies growing companies and strategic and financial with deep scientific in multi-jurisdictional businesses, including technology driven Wide-ranging and corporate finance business operations, Extensive experience of working in agricultural services experience, expertise patent litigation, mergers through operational and organisations knowledge of mergers acquisitions and commercialising science businesses throughout both through executive More than 30 years and acquisitions, patent cultural changes Led the strategic review and acquisitions, disposals, and corporate and innovation the world, including in and non-executive roles experience in academic licensing and managing Deep understanding of of Genus in 2012, financing, strategy and governance, gained Experienced scientific emerging markets Has advised numerous and commercial product life cycles in listed companies and resulting in a new vision, investor relations within the food sector adviser to companies, companies including research institutions complex areas corporate governance strategy, structure and Fellow of the Chartered Chartered accountant using his broad manufacturers and Current research focus Degrees in science core values Institute of Management perspective on life distributors of food is infectious diseases, andlaw BSc in Biochemistry Accountants sciences products, encompassing the microbiome and its from the University of Degree in Mathematics poultry and poultry impact on health and Wisconsin and an MBA from the University of breeding companies well-being from the University of Cambridge Michigan Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Non-Executive Chairman of Non-Executive Director of Financial Controller at Vice Chancellor of the Chair of Eden Research plc.
Chair of Grosvenor Group Co-founder and Board Eurocell plc.
Spectris plc and member Unilever plc and Unilever University of Melbourne.
and member of the Director of Auspherix: of the University of NV.
Remuneration committee: Board Director of Longas Michigan Ross School of Non-Executive Director Technologies Pty Limited: Business Advisory Board.
of Thomas Cook: and and Director of Quadram Non-Executive Director Institute Bioscience.
and Chair of the Remuneration Committee of Legal & General.
Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Past Appointments Chief Auditor of Unilever: Senior Vice President and Chief Executive of President of Lilly Executive Vice President Senior Independent Senior Pro-Vice Chancellor Member of the Board of Founder director of British Director of the ithree Electrocomponents plc, Europe, Canada and and Chief Financial Officer Director of Croda Chief Financial Officer PVC of the University Management of Bayer Linen Advisors: Governor institute, University of International Counsel of of Unilevers global food Shire plc: and senior and Managing Director of Vitec Australia: McKinsey and of Misys plc: finance and International Plc, Chairman of Cambridge, where he CropScience, a division of British Linen Bank Technology, Sydney: Group plc, Chairman of the Company consultant: business development of Numis Securities Ltd: service business: and a and the four other PVCs of Bayer AG: senior Group: and numerous co-founder and Chief global roles in Australia, number of other senior theUK and the US.
Federation of Groundwork and management roles roles at IBM: and NonDeputy Chairman of Numis were responsible for the international roles including non-executive roles, Scientific Officer of Arrow Trusts, Chairman of Hays at Johnson and Johnson, Executive Director and Corporation plc: Vice operational and financial Universitys strategy and the Head of Bayer including Centrica, SAB Therapeutics: founder positions within Unilever.
member of The Wolfson plc, and Non-Executive and the Dow Chemical Audit Committee Chair of Chairman of ABN AMROs policy development.
CropSciences BioScience Miller, Alliance Trust, Hays, Chairman of Barratt Company.
Wholesale and Investment division: and President Scottish Provident and Institute for BioMedical Research at University Developments plc.
Bank: and Partner and Head of the School of the of the Bayer HealthCare Bank of Scotland.
member of the Supervisory Biological Sciences at the Animal Health division.
College London: and Board at Lazard.
various roles at Glaxo University of Cambridge, leading research on Wellcome and Sheffield, Cambridge and Leicester infectious diseases of Key to Committees livestock and people.
1 Member of the Nomination Committee.
2 Member of the Remuneration Committee.
3 Member of the Audit Committee.
Genus plc | Annual Report 2018 S TR ATE G I C C OR P OR AT E F I NAN C I AL AD D I T I O final 45 R E P OR T G O V E R NAN C E S TAT EM EN T S IN F OR M AT I ON 1,2 1 1,2, 3 1,2, 3 1,2, 3 1,2, 3 Bob Lawson Karim Bitar Stephen Wilson Nigel Turner Lysanne Gray Professor Duncan Lykele van der Broek Lesley Knox Professor Ian Dan Hartley 1,2, 3 1,2, 3 Non-Executive Chief Executive Group Finance Director Senior Independent Non-Executive Director Maskell Non-Executive Director Non-Executive Director Charles Group General Counsel Chairman Non-Executive Director Audit Committee Chair Non-Executive Director Non-Executive Director and Company Nomination Remuneration Secretary Committee Chair Committee Chair Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Board Appointment Appointment November 2010 September 2011 January 2013 January 2008 April 2016 April 2014 July 2014 June 2018 July 2018 June 2014 Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Skills and Experience Significant experience Extensive experience International experience Substantial experience Significant experience of Co-founder of several Vast experience of Broad international, Entrepreneurial scientist, Significant experience of leading international of leading international, in France and the US of international business risk management, audit, biotech companies growing companies and strategic and financial with deep scientific in multi-jurisdictional businesses, including technology driven Wide-ranging and corporate finance business operations, Extensive experience of working in agricultural services experience, expertise patent litigation, mergers through operational and organisations knowledge of mergers acquisitions and commercialising science businesses throughout both through executive More than 30 years and acquisitions, patent cultural changes Led the strategic review and acquisitions, disposals, and corporate and innovation the world, including in and non-executive roles experience in academic licensing and managing Deep understanding of of Genus in 2012, financing, strategy and governance, gained Experienced scientific emerging markets Has advised numerous and commercial product life cycles in listed companies and resulting in a new vision, investor relations within the food sector adviser to companies, companies including research institutions complex areas corporate governance strategy, structure and Fellow of the Chartered Chartered accountant using his broad manufacturers and Current research focus Degrees in science core values Institute of Management perspective on life distributors of food is infectious diseases, andlaw BSc in Biochemistry Accountants sciences products, encompassing the microbiome and its from the University of Degree in Mathematics poultry and poultry impact on health and Wisconsin and an MBA from the University of breeding companies well-being from the University of Cambridge Michigan Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Current Appointments Non-Executive Chairman of Non-Executive Director of Financial Controller at Vice Chancellor of the Chair of Eden Research plc.
various roles at Glaxo University of Cambridge, leading research on Wellcome and Sheffield, Cambridge and Leicester infectious diseases of livestock and people.
